Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Globus Elite

Research Leaders

5 sponsors active, led by Universidad de Burgos

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 3 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total

Not Applicable (2)

Phase 3 (1)

Trial Status

Completed1

Recruiting1

Unknown1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (3)

Showing 3 of 3 trials

NCT06539312Not ApplicableRecruiting

Project ASTHMA - Aligning With Schools To Help Manage Asthma and Improve Outcomes

NCT06638775Not ApplicableUnknown

Functional Electrostimulation on the Upper Lip in Multiple Sclerosis

NCT00285883Phase 3CompletedPrimary

Directly Observed Therapy in High Risk Populations in Newark, NJ

Showing all 3 trials

Research Network

Common Treatments

Globus Elite1
App Assessment And Management Of Asthma1
Fesia Grasp1
Invirase1
Ritonavir1

Active Sponsors

Universidad de Burgos1
National Institute on Minority Health and Health Disparities (NIMHD)1
Saint Michael's Medical Center1
State University of New York at Buffalo1
Roche1

Directly Observed Therapy